Core Laboratories Ownership

CLB
 Stock
  

USD 21.97  0.47  2.19%   

Some institutional investors establish a significant position in stocks such as Core Laboratories in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Core Laboratories, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits. Continue to Trending Equities.
  
Core Laboratories Dividend Yield is projected to increase slightly based on the last few years of reporting. The past year's Dividend Yield was at 0.002. The current year Dividends per Basic Common Share is expected to grow to 0.0411, whereas Payment of Dividends and Other Cash Distributions is forecasted to decline to (2 M). The current year Issuance Purchase of Equity Shares is expected to grow to about 55.8 M, whereas Weighted Average Shares is forecasted to decline to about 43.1 M.
Core Laboratories retains a total of 46.37 Million outstanding shares. The majority of Core Laboratories NV outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Core Laboratories to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Core Laboratories. Please pay attention to any change in the institutional holdings of Core Laboratories NV as this could imply that something significant has changed or about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.

Core Laboratories Stock Ownership Analysis

About 99.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 0.53. Core Laboratories last dividend was issued on the 4th of November 2022. The entity had 2:1 split on the 9th of July 2010. Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company was founded in 1936 and is based in Amstelveen, the Netherlands. Core Laboratories is traded on New York Stock Exchange in the United States. For more info on Core Laboratories NV please contact Lawrence Bruno at 31 20 420 3191 or go to https://www.corelab.com.

Core Laboratories SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Core Laboratories prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Core Laboratories investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Core Laboratories specific information freely available to individual and institutional investors to make a timely investment decision.
27th of July 2022
Financial Statements and Exhibits. Regulation FD Disclosure. Results of Operations and Financial Condition
View
8th of June 2022
Other Events
View
19th of May 2022
Submission of Matters to a Vote of Security Holders
View
14th of February 2022
Unclassified Corporate Event
View

Core Laboratories Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Core Laboratories is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Core Laboratories NV backward and forwards among themselves. Core Laboratories' institutional investor refers to the entity that pools money to purchase Core Laboratories' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Zurcher Kantonalbank Zurich CantonalbankCommon Shares6.5 K88 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares6.5 K129 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares6.5 K206 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares6.5 K145 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares4.4 K122 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares4.4 K172 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares4.4 K127 K
Note, although Core Laboratories' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Core Laboratories Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Core Laboratories insiders, such as employees or executives, is commonly permitted as long as it does not rely on Core Laboratories' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Core Laboratories insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Mark Tattoli a day ago via Macroaxis 
Payment of tradable shares by Mark Tattoli of Core Laboratories subject to Rule 16b-3
Mark Tattoli over two months ago via Macroaxis 
Payment of 276 shares by Mark Tattoli of Core Laboratories subject to Rule 16b-3
Mark Tattoli over three months ago via Macroaxis 
Exercise or conversion by Mark Tattoli of 120 shares of Core Laboratories subject to Rule 16b-3
Murray Katherine over six months ago via Macroaxis 
Core Laboratories exotic insider transaction detected
Mark Tattoli over six months ago via Macroaxis 
Exercise or conversion by Mark Tattoli of 200 shares of Core Laboratories subject to Rule 16b-3
Kwaku Temeng over six months ago via Macroaxis 
Exercise or conversion by Kwaku Temeng of 4307 shares of Core Laboratories subject to Rule 16b-3
Tattoli Mark Damian over six months ago via Macroaxis 
Exercise or conversion by Tattoli Mark Damian of 110 shares of Core Laboratories subject to Rule 16b-3
Tattoli Mark Damian over six months ago via Macroaxis 
Acquisition by Tattoli Mark Damian of 17588 shares of Core Laboratories subject to Rule 16b-3
Christopher Hill over six months ago via Macroaxis 
Exercise or conversion by Christopher Hill of 23529 shares of Core Laboratories subject to Rule 16b-3
Gwendolyn Schreffler over six months ago via Macroaxis 
Exercise or conversion by Gwendolyn Schreffler of 4700 shares of Core Laboratories subject to Rule 16b-3
Tattoli Mark Damian over six months ago via Macroaxis 
Exercise or conversion by Tattoli Mark Damian of 160 shares of Core Laboratories subject to Rule 16b-3
Tattoli Mark Damian over a year ago via Macroaxis 
Acquisition by Tattoli Mark Damian of 6900 shares of Core Laboratories subject to Rule 16b-3

Be your own money manager

Our tools can tell you how much better you can do entering a position in Core Laboratories without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Probability Of Bankruptcy Now

   

Probability Of Bankruptcy

Get analysis of equity chance of financial distress in the next 2 years
All  Next Launch Module

Pair Trading with Core Laboratories

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Core Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Core Laboratories will appreciate offsetting losses from the drop in the long position's value.

Moving together with Core Laboratories

+0.9XPROExpro Group Holdings Upward RallyPairCorr
+0.94APAAPA Corporation Potential GrowthPairCorr
+0.82ARCHArch Resources Normal TradingPairCorr
The ability to find closely correlated positions to Core Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Core Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Core Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Core Laboratories NV to buy it.
The correlation of Core Laboratories is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Core Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Core Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Core Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Trending Equities. You can also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for analysis

When running Core Laboratories price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Is Core Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core Laboratories will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
7.47
Market Capitalization
B
Quarterly Revenue Growth YOY
0.068
Return On Assets
0.044
Return On Equity
0.0915
The market value of Core Laboratories is measured differently than its book value, which is the value of Core Laboratories that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine Core Laboratories value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.